Kto publikuje wyniki i kiedy, na najbliższe tygodnie. Kalendarz pochodzi ze źródła zewnętrznego; każdą liczbę obok — ocenę, wielkość, wskaźnik — liczymy z własnych raportów spółki złożonych do SEC.
W tym miesiącu zaplanowane 1232 spółki, z czego 1216 pokrywamy.
| Spółka | Ocena | Wielkość | C/Z | Dane |
|---|---|---|---|---|
A | 82,8B USD | 29,34 | — | |
B | 59,7B USD | 22,64 | — | |
B | 55,5B USD | 18,77 | — | |
D | 44,6B USD | 163,97 | — | |
C | 32,4B USD | 7,44 | — | |
| Spółka | Ocena | Wielkość | C/Z | Dane |
|---|---|---|---|---|
C | 345,9B USD | 16,65 | — | |
A | 207B USD | 65,65 | — | |
A | 169B USD | 29,74 | — | |
A | 158,3B USD | 19,31 | — | |
A | 136,7B USD | 72,48 | — | |
| 23,6B USD |
| 15,10 |
| — |
C | 6,8B USD | 75,94 | — |
C | 5,7B USD | 46,48 | — |
D | 3,2B USD | 34,11 | — |
B | 2B USD | — | — |
B | 1,2B USD | 5,55 | — |
D | 874,1M USD | — | — |
B | 698M USD | 98,38 | — |
| 121,9B USD |
| 1,23 |
| — |
A | 82,8B USD | — | — |
A | 80,2B USD | 30,45 | — |
A | 78B USD | 22,99 | — |
C | 76,2B USD | 29,37 | — |
D | 69,7B USD | 16,09 | — |
| TER | A | 63B USD | 55,40 | — |
| OKE | A | 54,8B USD | 14,98 | — |
| CARR | C | 46B USD | 36,20 | — |
| IQV | A | 44,9B USD | 33,40 | — |
| SYY | B | 37,6B USD | 21,45 | — |
| NMR | B | 28,8B USD | 13,08 | — |
| ATI | A | 25,7B USD | 55,42 | — |
| LH | B | 25B USD | 25,54 | — |
| INCY | A | 24,6B USD | 17,41 | — |
| HUBB | A | 24,3B USD | 27,12 | — |
| VLTO | A | 23,7B USD | 24,91 | — |
| XYL | A | 23,6B USD | 24,03 | — |
| VMRK | C | 23B USD | 26,55 | — |
| THC | A | 20,8B USD | 9,94 | — |
| AMRZ | C | 20,6B USD | 17,22 | — |
| EIX | B | 20,6B USD | 5,81 | — |
| EXE | A | 19,5B USD | 7,27 | — |
| WPC | C | 15B USD | — | — |
| SIM | D | 14,6B USD | — | — |
| LOGI | A | 14,4B USD | 18,48 | — |
| NBIX | A | 14,1B USD | 20,29 | — |
| ARCC | Bez oceny | 13,9B USD | 14,34 | — |
| INIO | Bez oceny | 13,8B USD | — | — |
| RNR | B | 13,5B USD | 5,43 | — |
| IVZ | A | 13,4B USD | — | — |
| CHKP | A | 13,4B USD | 13,00 | — |
| W | A | 13,4B USD | — | — |
| REG | A | 13,3B USD | — | — |
| SWKS | F | 13,2B USD | 45,60 | — |
| AIT | B | 12,3B USD | 30,70 | — |
| RGEN | A | 11B USD | 266,60 | — |
| CSGP | B | 10,9B USD | 141,84 | — |
| TX | F | 10,7B USD | 24,29 | — |
| AUR | D | 10,6B USD | — | — |
| QRVO | C | 10,3B USD | 32,24 | — |
| UMBF | A | 10B USD | 10,96 | — |
| BXP | A | 9,9B USD | 33,20 | — |
| MOD | B | 9,8B USD | 69,08 | — |
| FLS | C | 9,4B USD | 25,73 | — |
| ESI | C | 8,8B USD | 58,01 | — |
| RRC | B | 8,6B USD | 10,19 | — |
| AOS | B | 8B USD | 16,12 | — |
| ZWS | B | 7,8B USD | 37,76 | — |
| SFD | C | 7,5B USD | 7,09 | — |
| AXTA | B | 7B USD | 19,09 | — |
| MSA | A | 7B USD | 22,47 | — |
| AWI | A | 6,9B USD | 22,31 | — |
| ALKS | B | 6,8B USD | 107,37 | — |
| CHE | B | 6,7B USD | 25,76 | — |
| KNSA | A | 6,2B USD | 83,26 | — |
| ST | B | 6,1B USD | 69,80 | — |
| CVLT | A | 6,1B USD | 93,13 | — |
| CZR | B | 6B USD | — | — |
| VFC | B | 5,7B USD | 23,02 | — |
| VRNS | B | 5,4B USD | — | — |
| MMYT | A | 5,4B USD | 56,75 | — |
| CAKE | A | 5,3B USD | 29,09 | — |
| EXLS | B | 5,3B USD | 22,16 | — |
| AROC | A | 5,3B USD | 16,12 | — |
| CGAU | Bez oceny | 4,4B USD | — | — |
| FELE | B | 4,3B USD | 29,10 | — |
| HRI | A | 4,3B USD | 83,10 | — |
| ENPH | D | 4,2B USD | 31,86 | — |
| CECO | Bez oceny | 4,1B USD | — | — |
| MIR | A | 3,9B USD | 143,35 | — |
| SEB | F | 3,9B USD | — | — |
| UCTT | D | 3,6B USD | — | — |
| RNST | A | 3,6B USD | 11,64 | — |
| DBVT | F | 3,4B USD | — | — |
| HNI | C | 3,4B USD | — | — |
| ARQT | A | 3,4B USD | 127,33 | — |
| RCUS | D | 3,3B USD | — | — |
| KAI | A | 3,2B USD | 28,71 | — |
| LRN | A | 3,1B USD | 10,51 | — |
| ABG | B | 3,1B USD | 6,49 | — |
| PII | D | 3B USD | — | — |
| CURB | B | 2,9B USD | 90,05 | — |
| RRR | C | 2,9B USD | 17,26 | — |
| GPI | D | 2,9B USD | 9,97 | — |
| AKR | B | 2,6B USD | 84,85 | — |
| TRMK | A | 2,6B USD | 11,51 | — |
| HURN | B | 2,5B USD | 26,71 | — |
| BUSE | A | 2,4B USD | 12,09 | — |
| FCPT | A | 2,4B USD | 19,86 | — |
| APAM | B | 2,4B USD | 8,84 | — |
| NEO | B | 2,4B USD | — | — |
| IVT | A | 2,4B USD | 152,10 | — |
| NTB | B | 2,3B USD | 10,70 | — |
| MBIN | A | 2,3B USD | 9,97 | — |
| WGS | C | 2,3B USD | — | — |
| BLX | A | 2,1B USD | 9,09 | — |
| FCF | A | 2,1B USD | 12,47 | — |
| HYMC | Bez oceny | 1,8B USD | — | — |
| HOPE | C | 1,7B USD | 13,44 | — |
| CTS | C | 1,7B USD | 25,29 | — |
| JBLU | D | 1,6B USD | — | — |
| GIC | B | 1,6B USD | 19,00 | — |
| TRS | F | 1,4B USD | 1,64 | — |
| AAT | B | 1,3B USD | 73,55 | — |
| GBX | F | 1,3B USD | 12,17 | — |
| RYZ | D | 1,2B USD | — | — |
| AMTB | C | 1,1B USD | 20,95 | — |
| CPAC | A | 1B USD | 18,08 | — |
| CAC | A | 948,1M USD | 10,75 | — |
| FCBC | A | 892,9M USD | 14,89 | — |
| THFF | A | 883,3M USD | 10,40 | — |
| TTI | D | 861M USD | 193,83 | — |
| IBCP | A | 784,7M USD | 10,28 | — |
| BCAL | B | 688,7M USD | 11,58 | — |
| JBGS | F | 598,3M USD | — | — |
| KIDS | B | 595M USD | — | — |
| SSII | C | 574,1M USD | — | — |
| SFST | B | 563,2M USD | 12,81 | — |
| BRSP | C | 511,2M USD | — | — |
| NXRT | F | 492,5M USD | — | — |
| TRTX | B | 490,1M USD | 9,91 | — |
| ILPT | A | 479,2M USD | — | — |
| LXFR | D | 462,4M USD | 59,59 | — |
| QUAD | F | 460,8M USD | 16,59 | — |
| CHCT | B | 412,9M USD | 21,51 | — |
| ORN | B | 340,4M USD | 40,05 | — |
| RCKY | B | 339,8M USD | 11,87 | — |
| CLW | D | 312,4M USD | — | — |
| HRZN | Bez oceny | 311M USD | 11,90 | — |
| CBNA | A | 310,8M USD | 11,67 | — |
| FRAF | A | 280,7M USD | 11,36 | — |
| WNEB | C | 277,2M USD | 16,46 | — |
| GBFH | C | 271,3M USD | 14,60 | — |
| PAMT | F | 249,8M USD | — | — |
| QNBC | D | 227,4M USD | 13,55 | — |
| CWH | F | 219,5M USD | — | — |
| RBKB | C | 200M USD | 14,05 | — |
| PERF | B | 193M USD | 37,90 | — |
| FNWD | C | 182,3M USD | 18,54 | — |
| EBMT | B | 169,4M USD | 10,37 | — |
| ATOM | D | 164,7M USD | — | — |
| RVSB | F | 118,7M USD | — | — |
| SFBC | C | 117,5M USD | 14,67 | — |
| PROV | C | 114,5M USD | 17,83 | — |
| TYGO | D | 64,7M USD | 4,96 | — |
| TZOO | B | 56,5M USD | 198,59 | — |
| FSP | D | 37,3M USD | — | — |
| JL | A | 17,7M USD | 5,89 | — |
| MGIH | F | 16,3M USD | — | — |
| AQB | Bez oceny | 4,9M USD | — | — |
| ZDGE | A | 1,6M USD | — | — |
| AKO.Anie pokrywamy | Bez oceny | — | — | — |
| AKO.Bnie pokrywamy | Bez oceny | — | — | — |
| FMX | B | — | — | — |
| NBNnie pokrywamy | Bez oceny | — | — | — |
| V | B | — | — | — |